Biotech firm acquires 48% of AquaBounty
date:Nov 06, 2012
Virginia-based synthetic biology company Intrexon Corp. plans to buy a 48 percent interest in AquaBounty Technologies.

The largest shareholders for the Massachusetts-based company behind genetically engineered salmon have agreed to sell their combined holdings to Intrexon.

The purchase agreement states Intrexon will buy 48.6 million AquaBounty shares from Linnaeus Capital Partners and its subsidiary Tethys Ocean for USD 6 million, or about 12.3 cents per share. After the sale is final, the fou
1/4 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/21 04:24